EUVIMEDEUVIMED entdecken
Crossref

Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy

Jiawu Yu, Yuchen Zhang, Liqi Li, Yang Xiang, Xuemei Yao, Youbo Zhao, Kaiyong Cai, Menghuan Li, Zhongjun Li, Zhong Luo

Acta Biomaterialia · 2023

DOI: 10.1016/j.actbio.2023.07.042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023. Verfasst von Jiawu Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Chongqing University, Chongqing 400044, China. Hauptthemen laut MEDLINE: DNA, Catalytic, Breast Neoplasms, F-Box Proteins, Ferroptosis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Postdoctoral Research Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy is a mainstream modality for breast cancer treatment that employs ionizing radiation (IR) to damage tumor cell DNA and elevate ROS stress, which demonstrates multiple clinically-favorable advantages including localized treatment and low invasiveness. However, breast cancer cells may activate the p53-mediated cell cycle regulation in response to radiotherapy to repair IR-induced cellular damage and facilitate post-treatment survival. F-Box and WD Repeat Domain Containing 7 (FBXW7) is a promoter of p53 degradation and critical nexus of cell proliferation and survival events. Herein, we engineered a cooperative radio-ferroptosis-stimulatory nanomedicine through coordination-driven self-assembly between ferroptosis-inducing Fe2+ ions and FBXW7-inhibiting DNAzymes and further modification of tumor-targeting dopamine-modified hyaluronic acid (HA). The nanoassembly could be selectively internalized by breast cancer cells and disintegrated in lysosomes to release the therapeutic payload. DNAzyme readily abolishes FBXW7 expression and stabilizes phosphorylated p53 to cause irreversible G2 phase arrest for amplifying post-IR tumor cell apoptosis. Meanwhile, the p53 stabilization also inhibits the SLC7A11-cystine-GSH axis, which combines with the IR-upregulated ROS levels to amplify Fe2+-mediated ferroptotic damage. The DNAzyme-Fe-HA nanoassembly could thus systematically boost the tumor cell damaging effects of IR, presenting a simple and effective approach to augment the response of breast cancer to radiotherapy. STATEMENT OF SIGNIFICANCE: To overcome the intrinsic radioresistance in breast cancer, we prepared co-assembly of Fe2+ and FBXW7-targeted DNAzymes and modified surface with dopamine conjugated hyaluronic acid (HA), which enabled tumor-specific FBXW7-targeted gene therapy and ferroptosis therapy in IR-treated breast cancers. The nanoassembly could be activated in acidic condition to release the therapeutic contents. Specifically, the DNAzymes could selectively degrade FBXW7 mRNA in breast cancer cells to simultaneously induce accumulation of p53 and retardation of NHEJ repair, eventually inducing irreversible cell cycle arrest to promote apoptosis. The p53 stabilization would also inhibit the SLC7A11/GSH/GPX4 axis to enhance Fe2+ mediated ferroptosis. These merits could act in a cooperative manner to induce pronounced tumor inhibitory effect, offering new approaches for tumor radiosensitization in the clinics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, CatalyticBreast NeoplasmsF-Box ProteinsFerroptosisHumansFemaleF-Box-WD Repeat-Containing Protein 7Cell Cycle ProteinsTumor Suppressor Protein p53DopamineHyaluronic AcidReactive Oxygen SpeciesCell Line, TumorUbiquitin-Protein LigasesCell Cycle Checkpoints

Stichwörter der Autor:innen

Breast cancer therapyCoordination-driven self-assemblyDNAzyme-Fe nanocomplexFerroptosisGene deliveryRadiosensitization

Substanzen

F-Box-WD Repeat-Containing Protein 7DNA, CatalyticCell Cycle ProteinsF-Box ProteinsTumor Suppressor Protein p53DopamineHyaluronic AcidReactive Oxygen SpeciesUbiquitin-Protein LigasesFBXW7 protein, human

Autor:innen und Institutionen

  • School of Life Science, Chongqing University, Chongqing 400044, China.
  • Department of General Surgery, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.
  • Laboratory of Radiation Biology, Department of Blood Transfusion, Laboratory Medicine Centre, The Second Affiliated Hospital, Army Medical University, Chongqing, China.
  • Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, China.
  • School of Life Science, Chongqing University, Chongqing 400044, China. Electronic address: menghuanli@cqu.edu.cn.
  • Laboratory of Radiation Biology, Department of Blood Transfusion, Laboratory Medicine Centre, The Second Affiliated Hospital, Army Medical University, Chongqing, China. Electronic address: johnneyusc@gmail.com.

Förderung

  • China Postdoctoral Science Foundation
  • Postdoctoral Research Foundation of China
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Yu, J., Zhang, Y., Li, L., Xiang, Y., Yao, X., Zhao, Y., Cai, K., Li, M., Li, Z., & Luo, Z. (2023). Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2023.07.042

Vancouver

Yu J, Zhang Y, Li L, Xiang Y, Yao X, Zhao Y, et al. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy. Acta Biomaterialia. 2023. doi:10.1016/j.actbio.2023.07.042

BibTeX
@article{Yu2023,
  author = {Yu, Jiawu and Zhang, Yuchen and Li, Liqi and Xiang, Yang and Yao, Xuemei and Zhao, Youbo and Cai, Kaiyong and Li, Menghuan and Li, Zhongjun and Luo, Zhong},
  title = {Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy},
  journal = {Acta Biomaterialia},
  year = {2023},
  doi = {10.1016/j.actbio.2023.07.042}
}
Kostenlos starten →